|
[1]
|
Wong KC, Wu L.History of Chinese medicine. Being a chronicle of medical happenings in China from ancient times to the present period[J].Nature, 1933, 4(5):527-529. |
|
[2]
|
Bent S.Herbal medicine in the United States: review of efficacy, safety, and regulation[J].J Gen Intern Med, 2008, 23(6): 854-859. |
|
[3]
|
Yeh GY, Eisenberg DM, Kaptchuk TJ.Systematic review of herbs and dietary supplements for glycemic control in diabetes[J].Diabetes Care, 2003, 26(4): 1277-1294. |
|
[4]
|
Hopkins AL.Network pharmacology: the next paradigm in drug discovery[J].Nat Chem Biol, 2008, 4(11): 682-690. |
|
[5]
|
Chen C,Yang FQ, Zuo H, et al. Applications of biochromatography in the screening of bioactive natural products[J].J Chroma Sci, 2013, 51(8): 780-790. |
|
[6]
|
Luo H, Chen L, Li Z,et al.Frontal immunoaffinity chromatography with mass spectrometric detection:a method for finding active compounds from traditional Chinese herbs[J].Anal Chem, 2003, 75(16): 3994-3998. |
|
[7]
|
Zhao X, Li Q, Bian L,et al.Using immobilized G-protein coupled receptors to screen bioactive traditional Chinese medicine compounds with multiple targets[J].J Pharm Biomed Anal, 2012, 70: 549-552. |
|
[8]
|
Wang B, Deng J, Gao Y,et al.The screening toolbox of bioactive substances from natural products: a review[J].Fitoterapia, 2011, 82(8): 1141-1151. |
|
[9]
|
Wang L,Ren J,Sun M,et al.A combined cell membrane chromatography and online HPLC/MS method for screening compounds from Radix Caulophylli acting on the human α1A-adrenoceptor[J]. J Pharm Biomed Anal,2010,51(5):1032-1036. |
|
[10]
|
Zhang T, Han S, Huang J,et al.Combined fibroblast growth factor receptor 4 cell membrane chromatography online with high performance liquid chromatography/mass spectrometry to screen active compounds in Brassica albla[J].J Chromatogr B, 2013, 912: 85-92. |
|
[11]
|
Yue Y, Xue H, Wang X.High-expression β1 adrenergic receptor/cell membrane chromatography method based on a target receptor to screen active ingredients from traditional Chinese medicines[J].J Sep Sci, 2014, 37(3): 244-249. |
|
[12]
|
Chen X, Cao Y, Lv D, et al.Comprehensive two-dimensional HepG2/cell membrane chromatography/monolithic column/time of flight mass spectrometry system for screening anti-tumor components from herbal medicines[J].J Chromatogr A, 2012, 1242: 67-74. |
|
[13]
|
Yakufu P, Qi H, Li M,et al.CCR4 expressing cells cultured adherently on a capillary wall and formaldehyde fixed as the stationary phase for ligand screening by ACE[J].Electrophoresis, 2013, 34(4): 531-540. |
|
[14]
|
Woo CSJ, Lau JSH, El-Nezami H,et al.Herbal medicine: toxicity and recent trends in assessing their potential toxic effects[J].Adv Bot Res, 2012, 62: 365-384. |
|
[15]
|
Ye F, Wang H, Jiang S,et al.Quality evaluation of commercial extracts of scutellaria baicalensis[J].Nutr Cancer, 2004, 49(2): 217-222. |
|
[16]
|
Ren G, Fan X, Liang Q,et al.Screening and evaluation of traditional Chinese medicine by microarray expression analysis[J].J Ethnopharmacol, 2013, 147(3): 564-569. |
|
[17]
|
Liu M, Fan J, Wang S,et al.Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity[J].BMC Complement Altern Med, 2013, 13: 11-29. |
|
[18]
|
Song YN, Zhang H, Guan Y,et al.Classification of traditional Chinese medicine syndromes in patients with chronic hepatitis B by SELDI-Based proteinchip analysis[J].Evid Based Complement Alternat Med, 2012,2012:626320. |
|
[19]
|
Yao L, Dong W, Lu F,et al.An improved acute gouty arthritis rat model and therapeutic effect of Rhizoma dioscoreae nipponicae on acute gouty arthritis based on the protein-chip methods[J].Am J Chin Med, 2012, 40(1): 121-134. |
|
[20]
|
Carr JA, Parashar A, Gibson R,et al.A microfluidic platform for high-sensitivity, real-time drug screening on C. elegans and parasitic nematodes[J].Lab Chip, 2011, 11(14): 2385-2396. |
|
[21]
|
Sandoz A, Charvet I, Stoppini L,et al.Development of a microfluidic biochip for chronic monitoring of 3D neural tissues derived from human embryonic stem cells[J].Procedia Eng, 2013, 59: 46-50. |
|
[22]
|
Behr J.The Lock-and-Key principle, the state of the art-100 years on[M].Chichester:Wiley, 1995: 1-336. |
|
[23]
|
Hansch C.Quantitative approach to biochemical structure-activity relationships[J].Accounts Chem Res, 1969, 2(8): 232-239. |
|
[24]
|
Ge H, Wang Y, Li C,et al.Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing[J].J Chem Inf Model, 2013, 53(10): 2757-2764. |
|
[25]
|
Lyne PD.Structure-based virtual screening: an overview[J].Drug Discov Today, 2002, 7(20): 1047-1055. |
|
[26]
|
Irwin JJ, Shoichet BK.ZINC-a free database of commercially available compounds for virtual screening[J].J Chem Inf Model, 2005, 45(1): 177-182. |
|
[27]
|
Chan AH, Wereszczynski J, Amer BR,et al. Discovery of Staphylococcus aureus sortase a inhibitors using virtual screening and the relaxed complex scheme[J].Chem Biol Drug Des, 2013, 82(4): 418-428. |
|
[28]
|
Barlow DJ, Buriani A, Ehrman T,et al.In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date[J].J Ethnopharmacol, 2012, 140(3): 526-534. |
|
[29]
|
Pitt WR, Calmiano MD, Kroeplien B,et al. Structure-based virtual screening for novel ligands[J]. Methods Mol Biol, 2013,1008: 501-519. |
|
[30]
|
Ellingson SR, Dakshanamurthy S, Brown M,et al.Accelerating virtual high-throughput ligand docking: current technology and case study on a petascale supercomputer[J].Concurr Comp Pract E, 2013,26:1268-1277. |
|
[31]
|
Lavecchia A, Di Giovanni C.Virtual screening strategies in drug discovery: acritical review[J].Curr Med Chem, 2013, 20(23): 2839-2860. |
|
[32]
|
Karthick V, Ramanathan K.Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach[J].Springer Plus, 2013, 2(1): 115-124. |
|
[33]
|
Tian S, Sun H, Li Y,et al. Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures[J].J Chem Inf Model, 2013, 53(10): 2743-2756. |
|
[34]
|
Berger WT, Ralph BP, Kaczocha M,et al.Targeting fatty acid binding protein (FABP) anandamide transporters-a novel strategy for development of anti-inflammatory and anti-nociceptive drugs[J].PLos One, 2012, 7(12): e50968. |
|
[35]
|
Wang E, Bussom S, Chen J,et al.Interaction of a traditional Chinese medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment[J].BMC Med Genomics, 2011, 4(1): 38-50. |
点击查看大图
下载:
